{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:13:04Z","timestamp":1793167984213,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T00:00:00Z","timestamp":1606176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"UHCW charity"},{"name":"BRET Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Bile acid diarrhoea (BAD) is a common disorder resulting from increased loss of bile acids (BAs), overlapping irritable bowel syndrome with diarrhoea (IBS-D). The gut microbiota metabolises primary BAs to secondary BAs, with differing impacts on metabolism and homeostasis. The aim of this study was to profile the microbiome, metabolic products and bile acids in BAD. Patients with BAD diagnosed by SeHCAT testing, were compared with other IBS-D patients, and healthy controls. Faecal 16S ribosomal RNA gene analysis was undertaken. Faecal short chain fatty acid (SCFA) and urinary volatile organic compounds (VOCs) were measured. BAs were quantified in serum and faeces. Faecal bacterial diversity was significantly reduced in patients with BAD. Several taxa were enriched compared to IBS-D. SCFA amounts differed in BAD, controls and IBS-D, with significantly more propionate in BAD. Separation of VOC profiles was evident, but the greatest discrimination was between IBS-D and controls. Unconjugated and primary BA in serum and faeces were significantly higher in BAD. The faecal percentage primary BA was inversely related to SeHCAT. BAD produces dysbiosis, with metabolite differences, including VOC, SCFA and primary BAs when compared to IBS-D. These findings provide new mechanistic insights into the pathophysiology of BAD.<\/jats:p>","DOI":"10.1038\/s41598-020-77374-7","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T11:16:29Z","timestamp":1606216589000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["The pathophysiology of bile acid diarrhoea: differences in the colonic microbiome, metabolome and bile acids"],"prefix":"10.1038","volume":"10","author":[{"given":"Nidhi M.","family":"Sagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Duboc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma L.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad T.","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfian N.","family":"Wicaksono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Covington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Quince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margarita","family":"Kokkorou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vaios","family":"Svolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola J.","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Gerasimidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9720-5835","authenticated-orcid":false,"given":"Julian R. F.","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2231-3062","authenticated-orcid":false,"given":"Ramesh P.","family":"Arasaradnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,24]]},"reference":[{"key":"77374_CR1","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","volume":"30","author":"L Wedlake","year":"2009","unstructured":"Wedlake, L., A\u2019Hern, R., Thomas, K., Walters, J. R. F. & Andreyev, H. J. N. Systematic review: the prevalence of idiopathic bile acid malabsorption (I-BAM) as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome (IBS). Aliment. Pharmacol. Ther. 30, 707\u2013717 (2009).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"77374_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13227","volume":"42","author":"SA Slattery","year":"2015","unstructured":"Slattery, S. A., Niaz, O., Aziz, Q., Ford, A. C. & Farmer, A. D. Systematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment. Pharmacol. Ther. 42, 3\u201311 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"77374_CR3","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1136\/gutjnl-2017-315909","volume":"67","author":"RP Arasaradnam","year":"2018","unstructured":"Arasaradnam, R. P. et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology. Gut 67, 1380\u20131399 (2018).","journal-title":"Gut"},{"key":"77374_CR4","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","volume":"7","author":"JRF Walters","year":"2009","unstructured":"Walters, J. R. F. et al. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin. Gastroenterol. Hepatol. 7, 1189\u20131194 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77374_CR5","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1152\/physrev.00054.2017","volume":"98","author":"P Hegyi","year":"2018","unstructured":"Hegyi, P., Maleth, J., Walters, J. R., Hofmann, A. F. & Keely, S. J. Guts and gall: bile acids in regulation of intestinal epithelial function in health and disease. Physiol. Rev. 98, 1983\u20132023 (2018).","journal-title":"Physiol. Rev."},{"key":"77374_CR6","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1194\/jlr.R500013-JLR200","volume":"47","author":"JM Ridlon","year":"2006","unstructured":"Ridlon, J. M., Kang, D. J. & Hylemon, P. B. Bile salt biotransformations by human intestinal bacteria. J. Lipid Res. 47, 241\u2013259 (2006).","journal-title":"J. Lipid Res."},{"key":"77374_CR7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","volume":"30","author":"JM Ridlon","year":"2014","unstructured":"Ridlon, J. M., Kang, D. J., Hylemon, P. B. & Bajaj, J. S. Bile acids and the gut microbiome. Curr. Opin. Gastroenterol. 30, 332\u2013338 (2014).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"77374_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19490976.2019.1674124","volume":"11","author":"JA Winston","year":"2020","unstructured":"Winston, J. A. & Theriot, C. M. Diversification of host bile acids by members of the gut microbiota. Gut Microbes 11, 158\u2013171 (2020).","journal-title":"Gut Microbes"},{"key":"77374_CR9","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1172\/JCI106644","volume":"50","author":"HS Mekhjian","year":"1971","unstructured":"Mekhjian, H. S., Phillips, S. F. & Hofmann, A. F. Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man. J. Clin. Invest. 50, 1569\u20131577 (1971).","journal-title":"J. Clin. Invest."},{"key":"77374_CR10","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/j.1365-2982.2012.01893.x","volume":"24","author":"H Duboc","year":"2012","unstructured":"Duboc, H. et al. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol. Motil. 24, 513\u2013517 (2012).","journal-title":"Neurogastroenterol. Motil."},{"key":"77374_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.cgh.2013.04.020","volume":"11","author":"A Shin","year":"2013","unstructured":"Shin, A. et al. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome. Clin. Gastroenterol. Hepatol. 11, 1270\u20131275 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77374_CR12","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/j.cgh.2018.05.050","volume":"17","author":"P Vijayvargiya","year":"2019","unstructured":"Vijayvargiya, P. et al. Analysis of fecal primary bile acids detects increased stool weight and colonic transit in patients with chronic functional diarrhea. Clin. Gastroenterol. Hepatol. 17, 922\u2013929 (2019).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"77374_CR13","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1053\/j.gastro.2018.11.069","volume":"156","author":"P Vijayvargiya","year":"2019","unstructured":"Vijayvargiya, P. & Camilleri, M. Current practice in the diagnosis of bile acid diarrhea. Gastroenterology 156, 1233\u20131238 (2019).","journal-title":"Gastroenterology"},{"key":"77374_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1099\/jmm.0.46134-0","volume":"55","author":"J Maukonen","year":"2006","unstructured":"Maukonen, J. et al. Prevalence and temporal stability of selected clostridial groups in irritable bowel syndrome in relation to predominant faecal bacteria. J Med. Microbiol. 55, 625\u2013633 (2006).","journal-title":"J Med. Microbiol."},{"key":"77374_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-230X-9-95","volume":"9","author":"L Krogius-Kurikka","year":"2009","unstructured":"Krogius-Kurikka, L. et al. Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers. BMC Gastroenterol. 9, 95 (2009).","journal-title":"BMC Gastroenterol."},{"key":"77374_CR16","doi-asserted-by":"publisher","first-page":"G799","DOI":"10.1152\/ajpgi.00154.2011","volume":"301","author":"IM Carroll","year":"2011","unstructured":"Carroll, I. M. et al. Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 301, G799\u2013G807 (2011).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"77374_CR17","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","volume":"141","author":"M Rajilic-Stojanovic","year":"2011","unstructured":"Rajilic-Stojanovic, M. et al. Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology 141, 1792\u20131801 (2011).","journal-title":"Gastroenterology"},{"key":"77374_CR18","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/nmo.12829","volume":"28","author":"M Dior","year":"2016","unstructured":"Dior, M. et al. Interplay between bile acid metabolism and microbiota in irritable bowel syndrome. Neurogastroenterol. Motil. 28, 1330\u20131340 (2016).","journal-title":"Neurogastroenterol. Motil."},{"key":"77374_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1172\/JCI130976","volume":"130","author":"L Zhao","year":"2020","unstructured":"Zhao, L. et al. A Clostridia-rich microbiota enhances bile acid excretion in diarrhea-predominant irritable bowel syndrome. J. Clin. Invest. 130, 438\u2013450 (2020).","journal-title":"J. Clin. Invest."},{"key":"77374_CR20","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","volume":"158","author":"IB Jeffery","year":"2020","unstructured":"Jeffery, I. B. et al. Differences in fecal microbiomes and metabolomes of people with vs. without irritable bowel syndrome and bile acid malabsorption. Gastroenterology 158, 1016\u20131028 (2020).","journal-title":"Gastroenterology"},{"key":"77374_CR21","doi-asserted-by":"publisher","first-page":"398585","DOI":"10.1155\/2015\/398585","volume":"2015","author":"NM Sagar","year":"2015","unstructured":"Sagar, N. M., Cree, I. A., Covington, J. A. & Arasaradnam, R. P. The interplay of the gut microbiome, bile acids, and volatile organic compounds. Gastroenterol. Res. Pract. 2015, 398585 (2015).","journal-title":"Gastroenterol. Res. Pract."},{"key":"77374_CR22","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1517\/14712598.2014.880420","volume":"14","author":"ML Jones","year":"2014","unstructured":"Jones, M. L., Martoni, C. J., Ganopolsky, J. G., Labbe, A. & Prakash, S. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert. Opin. Biol. Ther. 14, 467\u2013482 (2014).","journal-title":"Expert. Opin. Biol. Ther."},{"key":"77374_CR23","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1096\/fj.06-6927com","volume":"21","author":"CE Garner","year":"2007","unstructured":"Garner, C. E. et al. Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEB J. 21, 1675\u20131688 (2007).","journal-title":"FASEB J."},{"key":"77374_CR24","doi-asserted-by":"publisher","first-page":"11899","DOI":"10.3390\/s130911899","volume":"13","author":"JA Covington","year":"2013","unstructured":"Covington, J. A. et al. Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) 13, 11899\u201311912 (2013).","journal-title":"Sensors (Basel)"},{"key":"77374_CR25","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1365-2036.1998.00337.x","volume":"12","author":"SI Cook","year":"1998","unstructured":"Cook, S. I. & Sellin, J. H. Review article: short chain fatty acids in health and disease. Aliment. Pharmacol. Ther. 12, 499\u2013507 (1998).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"77374_CR26","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3389\/fmicb.2016.00185","volume":"7","author":"D Rios-Covian","year":"2016","unstructured":"Rios-Covian, D. et al. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 7, 185 (2016).","journal-title":"Front. Microbiol."},{"key":"77374_CR27","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1053\/j.gastro.2011.07.046","volume":"141","author":"KB Islam","year":"2011","unstructured":"Islam, K. B. et al. Bile acid is a host factor that regulates the composition of the cecal microbiota in rats. Gastroenterology 141, 1773\u20131781 (2011).","journal-title":"Gastroenterology"},{"key":"77374_CR28","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1038\/ismej.2014.63","volume":"8","author":"A Salonen","year":"2014","unstructured":"Salonen, A. et al. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J. 8, 2218\u20132230 (2014).","journal-title":"ISME J."},{"key":"77374_CR29","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.3390\/nu7042930","volume":"7","author":"EP Neis","year":"2015","unstructured":"Neis, E. P., Dejong, C. H. & Rensen, S. S. The role of microbial amino acid metabolism in host metabolism. Nutrients 7, 2930\u20132946 (2015).","journal-title":"Nutrients"},{"key":"77374_CR30","doi-asserted-by":"publisher","first-page":"13580","DOI":"10.1073\/pnas.0804437105","volume":"105","author":"BV Jones","year":"2008","unstructured":"Jones, B. V., Begley, M., Hill, C., Gahan, C. G. & Marchesi, J. R. Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome. Proc. Natl. Acad. Sci. U. S. A 105, 13580\u201313585 (2008).","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"77374_CR31","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0022-4731(84)90404-7","volume":"20","author":"S Huijghebaert","year":"1984","unstructured":"Huijghebaert, S., Parmentier, G. & Eyssen, H. Specificity of bile salt sulfatase activity in man, mouse and rat intestinal microflora. J. Steroid. Biochem. 20, 907\u2013912 (1984).","journal-title":"J. Steroid. Biochem."},{"key":"77374_CR32","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/toxsci\/kfn268","volume":"108","author":"Y Alnouti","year":"2009","unstructured":"Alnouti, Y. Bile Acid sulfation: a pathway of bile acid elimination and detoxification. Toxicol. Sci. 108, 225\u2013246 (2009).","journal-title":"Toxicol. Sci."},{"key":"77374_CR33","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2020.07.001","author":"P Vijayvargiya","year":"2020","unstructured":"Vijayvargiya, P. et al. Combined fasting serum C4 and primary bile acids from a single stool sample diagnose bile acid diarrhea. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2020.07.001 (2020).","journal-title":"Gastroenterology"},{"key":"77374_CR34","doi-asserted-by":"publisher","first-page":"e0003861","DOI":"10.1371\/journal.pntd.0003861","volume":"9","author":"GL Kay","year":"2015","unstructured":"Kay, G. L. et al. Differences in the faecal microbiome in schistosoma haematobium infected children vs. uninfected children. PLoS Negl. Trop. Dis. 9, e0003861 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"77374_CR35","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/MIB.0000000000000023","volume":"20","author":"K Gerasimidis","year":"2014","unstructured":"Gerasimidis, K. et al. Decline in presumptively protective gut bacterial species and metabolites are paradoxically associated with disease improvement in pediatric Crohn\u2019s disease during enteral nutrition. Inflamm. Bowel. Dis. 20, 861\u2013871 (2014).","journal-title":"Inflamm. Bowel. Dis."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77374-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77374-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T23:36:31Z","timestamp":1670369791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-77374-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["77374"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-77374-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,24]]},"assertion":[{"value":"25 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N.S. received fees from Tillotts pharma for delivery of educational material. J.W. has been a consultant for, and reports institutional grant funding from G.E. Healthcare, Intercept Pharma, Metacrine, Novartis and Prometheus diagnostics. R.A. has received fees for delivery of educational talks for GE Healthcare. H.D., G.K., M.A., A.W., J.C., C.Q., M.K., V.S., L.P., K.G. have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20436"}}